You are here:

  1. Home
  2. NICE Guidance
  3. Published Guidance

MRI fusion biopsy systems for diagnosing prostate cancer

  • HealthTech guidance
  • Reference number: HTG678
  • Published:  24 May 2023
  • Guidance
  • Tools and resources
  • Information for the public
  • History

On this page

  1. Expected publication
  2. Declaration of interests
  3. Diagnostics consultation
  4. Stakeholder list updated
  5. Scope published
  6. Launch

History

Documents created during the development process.

Expected publication

  • Equality impact assessment (PDF 151 KB)

    Published:
    24 May 2023

Declaration of interests

  • Register of interests Standing committee members (PDF 230 KB)

    Published:
    24 May 2023
  • Register of interests Specialist committee members (PDF 194 KB)

    Published:
    24 May 2023

Diagnostics consultation

  • Diagnostics consultation

  • Diagnostics consultation document (Online commenting)

  • Diagnostics consultation document (PDF) (PDF 251 KB)

    Published:
    10 January 2023
  • Diagnostics assessment report (PDF 7.51 MB)

    Published:
    10 January 2023
  • Overview (PDF 531 KB)

    Published:
    10 January 2023
  • DAR Comments table and EAG response (PDF 219 KB)

    Published:
    10 January 2023
  • DAR Addendum (PDF 396 KB)

    Published:
    10 January 2023
  • DAR Erratum (PDF 304 KB)

    Published:
    10 January 2023

Stakeholder list updated

  • Stakeholder list (PDF 113 KB)

    Published:
    19 December 2022

Scope published

  • Final scope (PDF 459 KB)

    Published:
    13 May 2022
  • Final protocol (PDF 640 KB)

    Published:
    13 May 2022
  • Equality impact assessment (PDF 139 KB)

    Published:
    13 May 2022
  • Stakeholder list (PDF 112 KB)

    Published:
    13 May 2022
  • Specialist committee members (PDF 110 KB)

    Published:
    13 May 2022

Launch

  • Topic description (PDF 82 KB)

    Published:
    31 January 2022
Back to top